← Open Payments lookup

EMILY MOORE: Open Payments

NPI 1538827209 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,235 in 49 payments from 8 companies in 2025. Trend: 2023 $96 · 2024 $375 · 2025 $1,235

Food & beverage: $1,235
CompanyPaymentsAmount
Alkermes, Inc.18$430
Neurocrine BioSciences, Inc.13$348
Teva Pharmaceuticals USA, Inc.5$163
Janssen Pharmaceuticals, Inc6$131
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$102
E.R. Squibb & Sons, L.L.C.1$29
ABBVIE INC.1$17
Boston Scientific Corporation1$14

Products named: INGREZZA, ARISTADA, LYBALVI, UZEDY, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, COBENFY.

Industry payments across TX — which companies pay providers there.